Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Stage of Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02289300
What this trial is testing

Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients

Who this might be right for
Liver FibrosisHEPATITIS B CHRONICHepatocellular Carcinoma
A2 Healthcare Taiwan Corporation
Not applicableNot Yet RecruitingNCT07786792
What this trial is testing

Biomarker and Mechanism Study of Systemic Therapy in Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 400
Testing effectiveness (Phase 2)Looking for participantsNCT07801287
What this trial is testing

Iparomlimab/Tuvonralimab Plus SBRT and Lenvatinib for Perioperative Treatment of Potentially Resectable Intermediate-Stage HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00813293
What this trial is testing

Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer

Who this might be right for
Hepatocellular Cancer
Beth Israel Deaconess Medical Center 20
Not applicableStudy completedNCT01963429
What this trial is testing

Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCC

Who this might be right for
Recurrent Small Hepatocellular CarcinomaResidual Small Hepatocellular Carcinoma
National Cancer Center, Korea 144
Post-approval studies (Phase 4)Not Yet RecruitingNCT06311916
What this trial is testing

Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.

Who this might be right for
HCC
Chen Xiaoping 312
Testing effectiveness (Phase 2)WithdrawnNCT02908165
What this trial is testing

Randomized Phase II Trial of Chemoembolization and Sorafenib

Who this might be right for
Hepatocellular Carcinoma
Yale University
Not applicableUnknownNCT02187081
What this trial is testing

Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC

Who this might be right for
HCC
Southwest Hospital, China 380
Testing effectiveness (Phase 2)Study completedNCT03638141
What this trial is testing

CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab

Who this might be right for
Intermediate Stage of Hepatocellular CarcinomaHepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Testing effectiveness (Phase 2)Ended earlyNCT05537402
What this trial is testing

LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC

Who this might be right for
Hepatocellular Carcinoma
University of Texas Southwestern Medical Center 1
Not applicableStudy completedNCT05332496
What this trial is testing

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 941
Testing effectiveness (Phase 2)Study completedNCT02854839
What this trial is testing

MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
GC Cell Corporation 78
Testing effectiveness (Phase 2)UnknownNCT06090656
What this trial is testing

Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 88
Not applicableUnknownNCT04517227
What this trial is testing

The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD)

Who this might be right for
Hepatocellular Carcinoma
Fudan University 30
Not applicableStudy completedNCT01908322
What this trial is testing

Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety

Who this might be right for
Carcinoma, Hepatocellular
Bayer 19
Not applicableStudy completedNCT05281783
What this trial is testing

RFA for Treatment of Intermediate Stage HCC

Who this might be right for
Hepatocellular Carcinoma
Benha University 120
Testing effectiveness (Phase 2)Study completedNCT02856815
What this trial is testing

Safety and Efficacy of "Immuncell-LC" in TACE Therapy

Who this might be right for
Carcinoma, Hepatocellular
GC Cell Corporation 76
Large-scale testing (Phase 3)Looking for participantsNCT06041477
What this trial is testing

Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC

Who this might be right for
Hepatocellular CarcinomaChemotherapy EffectChemotherapeutic Toxicity
Sun Yat-sen University 540
Testing effectiveness (Phase 2)Study completedNCT00855218
What this trial is testing

A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC).

Who this might be right for
Carcinoma, Hepatocellular
Bayer 307
Not applicableLooking for participantsNCT06632093
What this trial is testing

HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatic Arterial Infusion Chemotherapy+3 more
First Hospital of China Medical University 84
Next Page